← Evidence map

ArticleCancers2023

Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer.

Dino Bekric et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36900361